StonvexLoading…
StonvexStonvexStonvexCore line items from XFOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $35.11M | $2.56M | $0.00 | $0.00 |
Operating Income | $-86.88M | $-36.40M | $-107.52M | $-87.57M |
Net Income | $-79.20M | $-37.45M | $-101.17M | $-93.87M |
EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 |
Total Assets | $290.46M | $146.45M | $147.26M | $155.59M |
Total Liabilities | $104.17M | $124.30M | $96.16M | $81.53M |
Cash & Equivalents | $217.05M | $55.70M | $99.22M | $121.72M |
Free Cash Flow OCF − CapEx | $-85.62M | $-131.23M | $-96.57M | $-77.20M |
Shares Outstanding | 90.91M | 5.70M | 167.43M | 121.67M |